【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Top Winning Strategies
3.3.1. Top Player Positioning, 2018
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Increased Consumption In Low And Middle-Income Countries (Lmics)
3.5.1.2. Rise In Prevalence of Infectious Diseases
3.5.1.3. Development of Novel Approaches For New Beta-Lactam And Beta-Lactamase Inhibitors For Treating Bacterial Infections
3.5.2. Restraints
3.5.2.1. Development of Beta-Lactam Resistance
3.5.2.2. Longer Approval Time By The Regulatory Bodies
3.5.3. Opportunity
3.5.3.1. Discovery of Advanced Prospect Molecules And Novel Combination Therapies To Treat Antibiotic-Resistant Microbial Infections
3.6. Antimicrobial Resistance And Countermeasure Trends
3.6.1. Countermeasure Trends
Chapter 4: Beta-Lactam And Beta Lactamase Inhibitors Market, By Drug Class
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Penicillin
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Cephalosporin
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Carbapenem
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Monobactam
4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country
4.6. Combination
4.6.1. Key Market Trends And Growth Opportunities
4.6.2. Market Size And Forecast, By Type
4.6.2.1. Penicillin/Beta Lactamase Inhibitors
4.6.2.1.1. Market Size And Forecast
4.6.2.2. Cephalosporins/Beta Lactamase Inhibitors
4.6.2.2.1. Market Size And Forecast
4.6.2.3. Carbapenems/Beta Lactamase Inhibitors
4.6.2.3.1. Market Size And Forecast
4.6.3. Market Size And Forecast, By Region
4.6.4. Market Analysis, By Country
Chapter 5: Beta-Lactam And Beta Lactamase Inhibitors Market, By Disease
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Urinary Tract Infection (Excluding Cuti)
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.3. Respiratory Infection
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Skin Infection
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country
5.5. Complicated Urinary Tract Infection (Cuti)
5.5.1. Market Size And Forecast, By Region
5.5.2. Market Analysis, By Country
5.5.3. Number of Patients, By Country
5.6. Complicated Intra-Abdominal Infections (Ciai)
5.6.1. Market Size And Forecast, By Region
5.6.2. Market Analysis, By Country
5.6.3. Number of Patients, By Country
5.7. Nosocomial Pneumonia
5.7.1. Market Size And Forecast, By Type
5.7.1.1. Hospital Acquired Pneumonia
5.7.1.1.1. Market Size And Forecast
5.7.1.2. Ventilator Associated Pneumonia
5.7.1.2.1. Market Size And Forecast
5.7.1.3. Other Nosocomial Pneumonia
5.7.1.3.1. Market Size And Forecast
5.7.2. Market Size And Forecast, By Region
5.7.3. Market Analysis, By Country
5.7.4. Number of Patients, By Country
5.8. Blood Stream Infection
5.8.1. Market Size And Forecast, By Region
5.8.2. Market Analysis, By Country
5.8.3. Number of Patients, By Country
5.9. Other Diseases
5.9.1. Market Size And Forecast, By Region
5.9.2. Market Analysis, By Country
Chapter 6: Beta-Lactam And Beta Lactamase Inhibitors Market, By Route of Administration
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Oral
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis, By Country
6.3. Intravenous
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country
6.4. Others
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis, By Country
Chapter 7: Beta-Lactam And Beta-Lactamase Inhibitors Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends And Opportunities
7.2.2. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country
7.2.2.1. U.S. Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.2.2.2. U.S. Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.2.2.3. U.S. Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.2.2.4. Canada Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.2.2.5. Canada Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.2.2.6. Canada Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.2.2.7. Mexico Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.2.2.8. Mexico Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.2.2.9. Mexico Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.2.3. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class
7.2.4. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease
7.2.5. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration
7.3. Europe
7.3.1. Key Market Trends And Opportunities
7.3.2. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country
7.3.2.1. Germany Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.3.2.2. Germany Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.3.2.3. Germany Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.3.2.4. France Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.3.2.5. France Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.3.2.6. France Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.3.2.7. Spain Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.3.2.8. Spain Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.3.2.9. Spain Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.3.2.10. Italy Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.3.2.11. Italy Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.3.2.12. Italy Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.3.2.13. Uk Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.3.2.14. Uk Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.3.2.15. Uk Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.3.2.16. Rest of Europe Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.3.2.17. Rest of Europe Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.3.2.18. Rest of Europe Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.3.3. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class
7.3.4. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease
7.3.5. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration
7.4. Asia-Pacific
7.4.1. Key Market Trends And Opportunities
7.4.2. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country
7.4.2.1. Japan Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.2. Japan Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.3. Japan Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.4. India Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.5. India Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.6. India Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.7. China Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.8. China Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.9. China Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.10. South Korea Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.11. South Korea Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.12. South Korea Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.13. Indonesia Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.14. Indonesia Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.15. Indonesia Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.16. Thailand Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.17. Thailand Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.18. Thailand Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.19. Vietnam Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.20. Vietnam Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.21. Vietnam Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.22. Taiwan Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.23. Taiwan Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.24. Taiwan Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.2.25. Rest of Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.4.2.26. Rest of Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.4.2.27. Rest of Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.4.3. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class
7.4.4. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease
7.4.5. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration
7.5. Lamea
7.5.1. Key Market Trends And Opportunities
7.5.2. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country
7.5.2.1. Brazil Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.5.2.2. Brazil Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.5.2.3. Brazil Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.5.2.4. Saudi Arabia Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.5.2.5. Saudi Arabia Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.5.2.6. Saudi Arabia Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.5.2.7. South Africa Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.5.2.8. South Africa Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.5.2.9. South Africa Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.5.2.10. Rest of Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market By Drug Class
7.5.2.11. Rest of Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market By Disease
7.5.2.12. Rest of Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market By Route of Administration
7.5.3. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class
7.5.4. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease
7.5.5. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration
Chapter 8: Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.2. Allergan Plc.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.2.6. Key Strategic Moves And Developments
8.3. F. Hoffmann-La Roche Ltd.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.4. Glaxosmithkline Plc
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.5. Merck & Co. Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves And Developments
8.6. Mylan N.V.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves And Developments
8.7. Novartis International Ag (Sandoz)
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.8. Pfizer Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves And Developments
8.9. Sanofi
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Teva Pharmaceutical Industries Ltd.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
【レポート販売概要】
■ タイトル：ベータラクタム及びベータラクタマーゼ阻害剤の世界市場：薬物クラス別、疾患別、投与経路別■ 英文：Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, and Combination), Disease (Urinary Tract Infection, Respiratory Infection, Skin Infection, Complicated Urinary Tract Infection (cUTI), Complicated Intra-Abdominal Infections (cIAI), Nosocomial Pneumonia, Blood Stream Infection, and Other Diseases), and Route of Administration (Oral, Intravenous, and Other Route of Administrations): Global Opportunity Analysis and Industry Forecast, 2019–2028
■ 発行日：2019年8月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV046
■ 調査対象地域：グローバル
- 下痢(Diarrhea)：世界の治験レビュー（2015年上半期版）Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2015" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe …
- 世界の企業NAS（Network Attached Storage）市場動向（2014-2018）About Enterprise NAS A NAS device is a computer storage device that is connected to a network to provide data storage and data retrieval/file-sharing services for heterogeneous clients and authorized network users. NAS devices allow several computers to simultaneously share the same storage space. By connecting a high-capacity NAS device to a network, all devices/computers in the network can easil …
- 口腔粘膜炎：グローバル臨床試験レビュー（2014年上半期）Oral Mucositis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Oral Mucositis Global Clinical Trials Review, H1, 2014" provides data on the Oral Mucositis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oral Mucositis. It includes an overview of the trial numbers and their recruitment status as per …
- 救急機サービスの世界市場分析：タイプ別（回転翼、固定翼）、サービスモデル別（コミュニティベース、病院ベース）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測 2014-2025The global air ambulance services market is expected to reach USD 8.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidents of life-threatening diseases, such as cardiovascular disorders, that require emergency medical response support the lucrative growth of the market over the forecast period. In addition, increasing awareness about air medical transport se …
- U.S. Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013U.S. Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary U.S. Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- ボディファーミングクリームの世界市場2019-2023About this market The rising demand for body care products in APAC will drive the body firming creams market growth during the forecast period. Rising awareness about personal appearance and growing consumer spending has resulted in the growing demand for body firming creams in the forthcoming years. In addition, rising number of domestic and international manufacturers are extending their presenc …
- 世界の製鋼市場（2014-2018）About Steel Steel is the main engineering material used in industries such as Construction, Automotive, Transport, Power, Mechanical Machinery, Metal Goods, and Domestic Appliances. It is also the main material utilized in delivering renewable energy such as solar, tidal, and wind power. Steel is composed of iron, carbon, impurities, and alloying elements, the combination of which determines the p …
- 軍用軽航空機の世界市場2016-2026Now: Why is the Military Aerostat important right now? As part of the broader Military Aerostat market space, there are significant revenue streams within the tethered aerostat submarket to tap into. This report shows you where these business opportunities are. Due to a myriad of real and perceived threats, never before have governments been so concerned with protecting their assets and infrastruc …
- 防護服の世界市場予測（～2021年）The global market size of protective clothing was USD 7.33 Billion in 2016, and is projected to reach USD 9.95 Billion by 2021, registering a CAGR of 6.3% during the forecast period. The increasing awareness and stringent regulations for use of protective clothing is expected to generate its high demand and drive the protective clothing market during the forecast period. The protective clothing ma …
- スマートホームM2M通信の世界市場2017-2021ABSTRACTAbout Smart Home M2M A smart home comprises of an internal network, home automation, and intelligent control. It is equipped with advanced and automated digital devices, home appliances, and equipment that are interconnected to each other. This facilitates sophisticated monitoring and control over the building's functions. Smart home devices perform three major actions — remote status chec …
- 世界のハロゲン電球市場2015The Global Halogen Bulbs Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Halogen Bulbs industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Halogen Bulbs market analysis is provided for the international markets including development trends, competit …
- 世界のマザーボード産業動向This research report presents industry size and value forecast and recent quarter review of the worldwide motherboard industry. The report includes shipment volume and value, shipment breakdowns by maker, ASP, and price trends. The report also examines manufacturer rankings, assembly levels, CPU connector adoption, production locations, shipment destinations, and business types, and provides assem …
- Pace Oil & Gas Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Pace Oil & Gas Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Pace Oil & Gas Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- Madhya Pradesh Power Generating Company Limited：発電所及び企業SWTO分析2015Madhya Pradesh Power Generating Company Limited - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plan …
- ナショナルブロードバンド計画：展開モデル分析Summary 'National Broadband Plans: Deployment Models and their Effectiveness in Improving Broadband Penetration,' a Research Report by Pyramid Research, provides information on national broadband plans and strategies of several countries across the globe. The report also includes projections of growth trends of broadband penetration and lines over 2014-2019 of different regions. It also has charts …
